These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 7374165)
1. Case report: malignant melanoma arising during drug therapy for vitiligo. Forrest JB; Forrest HJ J Surg Oncol; 1980; 13(4):337-40. PubMed ID: 7374165 [TBL] [Abstract][Full Text] [Related]
2. Oral trimethylpsoralen in the treatment of vitiligo. Theodoridis A; Tsambaos D; Sivenas C; Capetanakis J Acta Derm Venereol; 1976; 56(3):253-6. PubMed ID: 59512 [TBL] [Abstract][Full Text] [Related]
3. [Comparative analytical study of the effects of psoralens in vitiligo (findings in 70 patients) (author's transl)]. Bouattour H; Chaabouni M Ann Dermatol Venereol; 1978 May; 105(5):507-10. PubMed ID: 707943 [TBL] [Abstract][Full Text] [Related]
4. Photochemotherapy of vitiligo. Use of orally administered psoralens and a high-intensity long-wave ultraviolet light system. Parrish JA; Fitzpatrick TB; Shea C; Pathak MA Arch Dermatol; 1976 Nov; 112(11):1531-4. PubMed ID: 984858 [TBL] [Abstract][Full Text] [Related]
6. Cutaneous malignancies in patients treated with psoralen photochemotherapy (PUVA) for vitiligo. Halder RM; Battle EF; Smith EM Arch Dermatol; 1995 Jun; 131(6):734-5. PubMed ID: 7778934 [No Abstract] [Full Text] [Related]
7. Safety and therapeutic effectiveness of 8-methoxypsoralen, 4,5',8-trimethylpsoralen, and psoralen in vitiligo. Pathak MA; Mosher DB; Fitzpatrick TB Natl Cancer Inst Monogr; 1984 Dec; 66():165-73. PubMed ID: 6531024 [TBL] [Abstract][Full Text] [Related]
8. How we treat vitiligo. Kenney JA; Grimes PE Cutis; 1983 Oct; 32(4):347-8. PubMed ID: 6627994 [TBL] [Abstract][Full Text] [Related]
9. The early repigmentation pattern of vitiligo is related to the source of melanocytes and by the choice of therapy: a retrospective cohort study. Yang K; Xiong X; Pallavi G; Ling Y; Ding F; Duan W; Sun W; Ding G; Gong Q; Zhu W; Lu Y Int J Dermatol; 2018 Mar; 57(3):324-331. PubMed ID: 29318595 [TBL] [Abstract][Full Text] [Related]
10. Clinical study of repigmentation patterns with different treatment modalities and their correlation with speed and stability of repigmentation in 352 vitiliginous patches. Parsad D; Pandhi R; Dogra S; Kumar B J Am Acad Dermatol; 2004 Jan; 50(1):63-7. PubMed ID: 14699367 [TBL] [Abstract][Full Text] [Related]
11. Determination of optimal topical photochemotherapy for vitiligo. Grimes PE; Minus HR; Chakrabarti SG; Enterline J; Halder R; Gough JE; Kenney JA J Am Acad Dermatol; 1982 Dec; 7(6):771-8. PubMed ID: 7174915 [TBL] [Abstract][Full Text] [Related]
13. Carcinogenicity of trioxsalen bath PUVA. Hannuksela M; Karvonen J J Am Acad Dermatol; 1989 Oct; 21(4 Pt 1):813-4. PubMed ID: 2808807 [No Abstract] [Full Text] [Related]
14. An approach to the treatment of vitiligo by khellin. Abdel-Fattah A; Aboul-Enein MN; Wassel GM; El-Menshawi BS Dermatologica; 1982 Aug; 165(2):136-40. PubMed ID: 6754485 [TBL] [Abstract][Full Text] [Related]
15. Epidermoid carcinoma of the gingiva: a possible relationship to PUVA therapy. Krutchkoff DJ; Eisenberg E; Neckritz AA Oral Surg Oral Med Oral Pathol; 1981 Jul; 52(1):44-50. PubMed ID: 6944677 [TBL] [Abstract][Full Text] [Related]
16. Trimethoxypsoralen in vitiligo. Annamalai R; Subhan SA; Vasantha M; Lal MB Int J Dermatol; 1976 Nov; 15(9):690-3. PubMed ID: 977211 [TBL] [Abstract][Full Text] [Related]
17. A case of chronic urticaria and vitiligo, associated with thyroiditis, treated with PUVA. Midelfart K; Moseng D; Kavli G; Stenvold SE; Volden G Dermatologica; 1983; 167(1):39-41. PubMed ID: 6628797 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness of psoralen photochemotherapy for vitiligo. Chuan MT; Tsai YJ; Wu MC J Formos Med Assoc; 1999 May; 98(5):335-40. PubMed ID: 10420701 [TBL] [Abstract][Full Text] [Related]
20. Psoralen plus ultraviolet A irradiation-induced lentigines arising in vitiligo: involvement of vitiliginous and normal appearing skin. Abdel Naser MB; Wollina U; El Okby M; El Shiemy S Clin Exp Dermatol; 2004 Jul; 29(4):380-2. PubMed ID: 15245535 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]